In vitrodrug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemia
- 1 July 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 102 (2), 528-531
- https://doi.org/10.1046/j.1365-2141.1998.00813.x
Abstract
We investigated the possible value of an in vitro drug-induced cytotoxicity assay in predicting clinical response to fludarabine (FAMP) in chronic lymphocytic leukaemia (CLL). The median FAMP-LD50 values for cases designated as complete response (CR), partial response (PR), no response (NR) and progressive disease (PD) were 1.43, 2.05, 24.8 and 77.9 μg/ml, respectively (P=0.013). A significant lower mean FAMP-LD50 value was observed in the in vivo responding cases as compared to non-responding ones (3.0 ± 0.82 SEM v 42.3 ± 12.6 SEM, P=0.001). Only FAMP-LD50 2.5 μg/ml and more than four FAMP courses significantly influenced the response rate in univariate and multivariate analyses. The MTT assay may be of value in predicting clinical response to FAMP in CLL patients.Keywords
This publication has 7 references indexed in Scilit:
- Chronic lymphocytic leukemia treatment.Hematology and Cell Therapy, 1997
- Fludarabine ability to down‐regulate Bcl‐2 gene product in CD5+ leukaemic B cells: in vitro/in vivo correlationsBritish Journal of Haematology, 1997
- Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemiaThe Lancet, 1996
- Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogsBlood, 1994
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- 9-?-D-Arabinofuranosyl-2-fluoroadenine 5?-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphomaCancer Chemotherapy and Pharmacology, 1986
- Total Tumour Mass Score (TTM): a New Parameter in Chronic Lymphocytic LeukaemiaBritish Journal of Haematology, 1981